glp-1 medication semaglutide Details of failed studies cast pall on Novo Nordisk's as Alzheimer's treatment Decoding GLP-1 Weight Loss Medications

However, these events were mostly mild to moderate in severity and were partially mitigated by using a lower starting dose

Check this blog article where I share my clinical thoughts on that

Michael, et al

Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of double-blind, randomized, placebo-controlled clinical trials

DACT2 protects against pulmonary fibrosis via suppressing glycolysis in lung myofibroblasts

Although the results are not directly comparable due to differences in study designs, what we know suggests retatrutide may be more effective